NV

Nishtha Vijaywargi

Active Director Director DIN 06684914
DIN 06684914 First appointment Nov 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2013
Shareholding value •••• Premium profile

About Nishtha Vijaywargi

Data last updated:

Nishtha Vijaywargi is a Director at Fab Biotech Private Limited (since 2013). The company operates in Pharma. Fab Biotech Private Limited reported revenue of ₹52.3 Lakh (FY 2025).

DIN 06684914
Primary Designation Director
Industry Pharma
First Appointment 08 Nov 2013
Oldest Company Age 12 yrs
Largest company Fab Biotech Private Limited · ₹52.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fab Biotech Private Limited U24100UP2013PTC060527
Director08 Nov 20132013₹52.3 Lakh (FY 2025)Active

Board colleagues of Nishtha Vijaywargi

Directorship timeline

Open interactive timeline →
Fab Biotech Private Limited
Premium access

Shareholding and investment profile for Nishtha Vijaywargi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nishtha Vijaywargi

Nishtha Vijaywargi currently holds 1 directorship: Fab Biotech Private Limited (Director, since 08 Nov 2013, revenue ₹52.3 Lakh (FY 2025)).

Nishtha Vijaywargi was first appointed on 08 Nov 2013 as Director at Fab Biotech Private Limited.

The current boards of Nishtha Vijaywargi's companies include Bhagwan Das Vijayvergiya (Fab Biotech Private Limited), Sudhanshu Vijay (Fab Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available